Form D — ABLi Therapeutics, Inc.
0002104142-26-000001 · filed 2026-01-13
Offering
- Industry
- Pharmaceuticals
- Exemptions
- 06b
- Total offering
- $1,000,000
- Total sold
- $1,000,000
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- ABLi Therapeutics, Inc.
- CIK
- 2104142
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- 2025
- Address
- 3350 RIVERWOOD PKWY SE
ATLANTA, GA 30339 - Phone
- 917-494-0831
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Milton H. Werner · Executive OfficerAtlanta, GA Find on LinkedIn ↗
-
Garth Lees-Rolfe · Executive OfficerAtlanta, GA Find on LinkedIn ↗
-
Anastasia Daifotis · DirectorAtlanta, GA Find on LinkedIn ↗
-
Jeffrey Young · DirectorAtlanta, GA Find on LinkedIn ↗
View original on SEC EDGAR.